Lataa...
Dexamethasone enhances the antitumor efficacy of Gemcitabine by glucocorticoid receptor signaling
Gemcitabine (Gem) is currently used as the first-line therapy for liver and pancreatic cancer but has limited efficacy in most cases. Dexamethasone (Dex) have been applied as a chemoprotectant and chemosensitizer in cancer chemotherapy. This study further explored the potential of combination of Gem...
Tallennettuna:
| Julkaisussa: | Cancer Biol Ther |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515523/ https://ncbi.nlm.nih.gov/pubmed/31906826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2019.1702399 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|